StockNews.com lowered shares of LeMaitre Vascular (NASDAQ:LMAT – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Saturday. Separately, Roth Capital reaffirmed a neutral rating on shares of LeMaitre Vascular in a research report on Tuesday, March 7th. LeMaitre Vascular Price Performance Shares of LMAT stock […]
Congress Asset Management Co. MA cut its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) by 19.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,806 shares of the medical instruments supplier’s stock after selling 2,836 shares during the […]
Values First Advisors Inc. lowered its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) by 2.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,798 shares of the medical instruments supplier’s stock after selling 897 shares during the […]
BURLINGTON, Mass., March 03, 2023 (GLOBE NEWSWIRE) LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in four.